- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT00546390
Protection of the Heart With Remote Ischemic Preconditioning During Heart Surgery: A Pilot Study
Panoramica dello studio
Stato
Intervento / Trattamento
Descrizione dettagliata
Purpose:
- Determine, in a pilot study, if surrogate markers of rIP can be detected in patients presenting for cardiac surgery. Specifically measure the effect of rIP on the expression profile of HSP-70, iNOS, PKC-E, p38 MAPK, PI3K, and sarcolemmal KATP
- Determine if rIP influences the expression of genes known to influence substrate preference and thereby myocardial metabolism in patients undergoing heart surgery. Specifically the expression of HIF-1a, PPAR-a and AMPK
Hypothesis:
We hypothesize that rIP provides myocardial protection in patients presenting for heart surgery and that this protection is defined by a distinct gene expression profile with regards to genes involved in rIP and myocardial metabolism.
Study Design:
This proposal is for a randomized blinded pilot study on the use of rIP in patients requiring heart surgery.
Study Population:
The study will include 100 male and female patients undergoing elective heart surgery with cardiopulmonary bypass (CPB).
Randomization:
Patients will be randomized 1:1 to receive either rIP or no treatment.
Blinding Procedures:
The patient will be blinded as well as those performing the experimental analysis.
Interventions:
Remote Ischemic Preconditioning
rIP will be induced immediately following induction of anesthesia. Four 5 minute cycles of lower unilateral limb ischemia and reperfusion induced tourniquet inflation to 300 mmHg will constitute the preconditioning stimulus.
Blood sample collection/analysis
- Two cardiac biopsies (50 - 200 mg) will be collected pre-bypass and post- bypass and will be analyzed for gene and protein expression.
- Blood samples (4 mL) will be drawn immediately before induction of anesthesia, and at the same times as cardiac tissue samples are harvested and analyzed for gene/protein expression as well as at 1, 24, 48 and 72 hours post surgery. Troponin I and NT-ProBNP will be measured at baseline, 1, 24, 48 and 72 hours after surgery and 3 mL of blood will be collected for these tests. A total of 43 mL of blood will be collected per patient.
- rIP induced changes in leukocyte gene expression will be measured at the aforementioned time points.
Other
ECG assessment on post-operative day 1, 2, and 3.
National Institute of Health stroke scale assessment will be conducted at screening and post operatively prior to hospital discharge.
Each patient will receive a telephone follow-up call at 30 days post operatively to collect adverse events and mortality data.
Experimental Methods:
- qRT-PCR will be used to measure gene expression.
- Immunoblotting will be used to measure protein expression
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Alberta
-
Edmonton, Alberta, Canada, T6G 2G3
- University of Alberta
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Written informed consent
- Age 18 through 80 years, inclusive
- Scheduled for heart surgery with CPB
Exclusion Criteria:
- Females of childbearing potential
- Emergency surgery
- Previous sternotomy
- Myocardial infarction within 48 hours prior to surgery
- Diabetes and/or BMI >35
- Need for Alpha2-agonists perioperatively
- Peripheral Vascular Disease
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Sperimentale: Ischemic Preconditioned Group (rIP)
A 15-cm sterile blood pressure cuff was placed around the right thigh and connected to the inflating device, and the patient was draped obscuring the visibility of the cuff.
Subsequently, the patient was randomly allocated (by opening of an envelope) to RIPC consisting of four 5-min cycles of lower limb ischemia-reperfusion induced by a tourniquet inflated to 300 mmHg
|
The blood pressure cuff will be inflated for 5 minutes and then deflated for 5 minutes.
This will be done 4 times in a row.
|
Nessun intervento: No Cuff
No rIP
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Myocardial Protection Against Ischemic Injury
Lasso di tempo: 72 hours post operatively
|
High-sensitivity cardiac troponin T release as measured by peak hscTnT values and area-under-the-curve.
|
72 hours post operatively
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
All-cause Death and Cardiovascular Long-term Outcome
Lasso di tempo: 6-month cardiovascular outcome
|
Death and re-hospitalization due to any cause including heart and renal failure and new atrial fibrillation
|
6-month cardiovascular outcome
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Barry A Finegan, MB, University of Alberta
Pubblicazioni e link utili
Collegamenti utili
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- PROTEcT
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Blood Pressure Cuff
-
Haydarpasa Numune Training and Research HospitalCompletatoDisturbo della coagulazioneTacchino
-
Smith & Nephew, Inc.CompletatoStrappo della cuffia dei rotatoriStati Uniti
-
Joseph D. TobiasCompletatoPazienti intubati con tubo endotracheale cuffiatoStati Uniti
-
Cerus CorporationReclutamento
-
University Hospital, RouenNon ancora reclutamentoEpatite B | Epatite C | AIDSFrancia
-
MicroPhage, Inc.CompletatoSepsi | Batteriemia | Infezione | Infezione da stafilococcoStati Uniti
-
D. Patrick WilliamsLake Erie College of Osteopathic MedicineRitirato
-
University Hospital TuebingenReclutamentoPredisposizione genetica alla malattia | Malattie RareGermania
-
University of UtahAlbert Einstein College of Medicine; University of California, San Francisco; National... e altri collaboratoriCompletato
-
University of AlbertaAlberta Innovates Health SolutionsCompletatoMalattia renale allo stadio terminaleCanada